Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 RSSL Opens New Metals Lab | Contract Pharma

What are you searching for?

Sign in
Breaking News

RSSL Opens New Metals Lab

Gears up for USP changes

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

RSSL has opened its new metals laboratory and has signed a lab partnership agreement with Agilent. The newly expanded lab allows RSSL to provide enhanced services in routine metals testing for the pharma industry. RSSL’s investment is in response to the pending implementation of Chapter and Chapter of the USP, and the existing European Pharmacopoeia Chapters 2.4.20 and 5.20, which deal with the analysis of heavy metals by modern spectroscopic methods.
 
New equipment has been added to enhance current capabilities, and includes ICP-MS (inductively coupled plasma mass-spectrometry), ICP-OES (inductively coupled plasma optical emission spectroscopy), AAS (atomic absorption spectrometry), and MP-AES (microwave plasma-atomic emission spectrometry). The pending changes to the USP for heavy metals testing indicate that spectroscopic methods are set to replace wet-chemistry methods. RSSL is now and better equipped to carry out heavy metals testing for the international pharma/healthcare industry.
 
As Agilent’s sole lab partner in the UK for atomic spectroscopy, RSSL will also develop new techniques and applications for Agilent’s technologies and offer a demonstration site for Agilent equipment.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics